Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyldgaard

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
European Heart Journal. Imaging Methods and Practice|January 12, 2026
Impact of myocardial perfusion abnormalities on clinical outcomes in patients treated with percutaneous coronary intervention for chronic total occlusionsJesper Boes Henningsen, Marc Meller Søndergaard, Steen Hyldgaard Jørgensen, et al.
Early Intervention in Psychiatry|January 24, 2016
Relation between premorbid adjustment, duration of untreated psychosis and close interpersonal trauma in first-episode psychosisUlrik Helt Haahr, Tor Ketil Larsen, Erik Simonsen, et al.
Ugeskrift for Laeger|April 14, 2023
Susanne Sloth Osther, Karin Andersen, Margrethe Andersen, et al.
Trials|September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.
Neurology|November 11, 2018
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Zsolt Illes, Melinda Magyari, et al.
Scandinavian Journal of Urology|March 26, 2026
Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys studyTiia Venhomaa, Ilkka Nikulainen, Johannes Bobjer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
European Heart Journal. Imaging Methods and Practice|January 12, 2026
Impact of myocardial perfusion abnormalities on clinical outcomes in patients treated with percutaneous coronary intervention for chronic total occlusionsJesper Boes Henningsen, Marc Meller Søndergaard, Steen Hyldgaard Jørgensen, et al.
Early Intervention in Psychiatry|January 24, 2016
Relation between premorbid adjustment, duration of untreated psychosis and close interpersonal trauma in first-episode psychosisUlrik Helt Haahr, Tor Ketil Larsen, Erik Simonsen, et al.
Ugeskrift for Laeger|April 14, 2023
Susanne Sloth Osther, Karin Andersen, Margrethe Andersen, et al.
Trials|September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.
Neurology|November 11, 2018
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Zsolt Illes, Melinda Magyari, et al.
Scandinavian Journal of Urology|March 26, 2026
Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys studyTiia Venhomaa, Ilkka Nikulainen, Johannes Bobjer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Pageof 18